Variables | Case (n = 116) | Control (n = 231) |
---|---|---|
Frequency(percentage) | Frequency (percentage) | |
Base line hematology test done | ||
 Yes | 75 (64.7%) | 153 (66.2%) |
 No | 41(33.3 5%) | 78 (33.8%) |
CD4 measurement done at base line | ||
 Yes | 87 (75%) | 166 (71.9%) |
 No | 30 (25%) | 65 (29. 1%) |
CD4 result (NÂ =Â 253) | ||
  < 100 cell/micro liter | 26 (22.4%) | 18 (7.8%) |
 100-200 cell/micro liter | 25 (21.6%) | 26 (11.3%) |
 > 200 cell/micro liter | 36 (31%) | 122 (52.8%) |
Adherence level | ||
 Good | 82 (70.7%) | 221(95.7%) |
 Fair | 13 (11.2%) | 2 (0.87%) |
 Poor | 21 (18.1%) | 8 (3.5%) |
Disclosure of sero-status | ||
 Yes | 81(69.8%) | 136 (58.9%) |
 No | 35 (30. 2%) | 95 (41.1%) |
BMI | Â | Â |
  < 18 kg/m2 | 26 (22.4%) | 59 (25.5%) |
 18.5-25 kg/m2 | 88 (75.9%) | 153 (66.2%) |
 > 25 kg/m2 | 2 (1.7%) | 19(8.2%) |
Baseline WHO clinical stage | ||
 Stage I | 62 (53.4%) | 141 (61%) |
 Stage II | 15 (12.9%) | 23 (10%) |
 Stage III | 33 (28.4%) | 54 (23.4%) |
 Stage IV | 6 (25.6%) | 13 (5.6%) |
Baseline functional status | ||
 Working | 101 (87.2%) | 208 (90%) |
 Ambulatory | 12 (10.3%) | 20 (8.7%) |
 Bedridden | 3(2.5%) | 3 (1.3%) |
History of OI | ||
 Yes | 28 (24.1%) | 42(18.2%) |
 No | 88 (73.9%) | 189(81.8%) |
History of chronic diarrhea | ||
 Yes | 18 (15.5%) | 29 (12.6%) |
 No | 98 (84. 5%) | 202 (85.4%) |
History of chronic gastric problem | ||
 Yes | 8 (6.9%) | 26 (11.3%) |
 No | 108 (93.1%) | 205 (88.7%) |